It seems likely that Navigenics' higher fees are part of its overall strategy to paint itself as the more serious and respectable member of the personal genomics industry, and to appeal to the kind of well-paid executive customer who sees higher prices as a sure sign of quality.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Navigenics' lame attempt at cut-price genetics
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account